Bellevue Group AG

Q2 2025 13F Holdings Report, Stock Holdings

Signature - Title
Christoph Eisenring / Stefano Montalbano - Head Legal & Compliance / CFO
Location
Zurich
Holdings as of
June 30, 2025
Value $
$4.54B
Num holdings
142
Date filed
8/14/2025, 03:15 PM
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included ARGX, IONS, NBIX, ALNY, and ABT.
Previous filing
Q1 2025 - May 14, 2025
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2025 Q2 compared to 2025 Q1 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Christoph Eisenring / Stefano Montalbano Head Legal & Compliance / CFO Zurich, Switzerland 8/7/2025

Other Included Managers (3):

Num Name Location File Number
1 Bb Biotech Ag Schaffhausen, Switzerland 028-06964
2 Bellevue Asset Management AG Kuesnacht, Switzerland 028-16892
3 Bellevue Asset Management (UK) Ltd. London, United Kingdom 028-20408